Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
World Health Day: HDA’s Commitment to a More Sustainable, Resilient Supply Chain
The World Health Organization has estimated that more than 13 million deaths around the globe are due to avoidable environmental causes stemming from climate change. Accordingly, this year’s World Health Day (April 7) theme is “Our Planet, Our Health,” which focuses on the political, social and commercial decisions that affect the environment as a factor in human health. The public and private sectors each can do their part on this front — and HDA believes that healthcare distributors have an important role to play in the health of the planet when it comes to delivering medications sustainably.
Driving the Future of the Healthcare Supply Chain
The Milken Institute’s 2023 Future of Health Summit brought together policymakers, patient advocates, healthcare workers and other leading public health experts to discuss critical issues shaping the healthcare landscape. As part of the event, Kirk Kaminsky, HDA Chairman and McKesson President of U.S. Pharmaceutical, joined panelists to discuss the future of the healthcare supply chain.
Pennsylvania Healthcare Community Launches Effort to Improve Supply Chain Integration and Collaboration
The Pennsylvania Healthcare Supply Chain Leadership Alliance (PA-HSCLA) convened the Commonwealth’s healthcare and provider industry today to launch a collective effort aimed at creating a more resilient healthcare product supply chain in the Commonwealth.
Healthcare Distributors Playing Central Role As COVID-19 Vaccination Campaign Accelerates
We have reached another pivotal moment in the fight against COVID-19: the Food and Drug Administration (FDA) has authorized Johnson & Johnson’s COVID-19 vaccine candidate for emergency use. With demand for vaccines currently outpacing supply, the addition of a third candidate is welcome news for Americans. Most importantly, a one-dose option that only requires refrigeration will provide greater flexibility in delivering vaccines to more individuals, including those in underserved and rural areas, with the ability to scale up production exponentially as we move into the spring and summer months.